Bleichroeder LP Cti Biopharma Corp Transaction History

Bleichroeder LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$4.45 - $6.17 $222,500 - $308,500	-50,000 Reduced 1.27%	3,893,730 $23.4 Million
Q3 2022 Nov 14, 2022	SELL	$5.36 - $7.43 $26,800 - $37,150	-5,000 Reduced 0.13%	3,943,730 $23 Million
Q2 2022 Aug 10, 2022	BUY	$3.55 - $6.27 $316,031 - $558,174	89,023 Added 2.31%	3,948,730 $23.6 Million
Q1 2022 May 11, 2022	BUY	$1.9 - $5.23 $6.86 Million - $18.9 Million	3,609,707 Added 1443.88%	3,859,707 $18 Million
Q4 2021 Feb 10, 2022	BUY	$1.44 - $2.86 $360,000 - $715,000	250,000 New	250,000 $620,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Bleichroeder LP, based on Form 13F filings with the SEC.

Stay updated on Bleichroeder LP with notifications on news.